RACK1 and hepatocellular carcinoma: Previous research has shown that RACK1 can act as either a tumor suppressor or an oncogene, depending on the cancer type (Deng et al. 2012; Xiao et al. 2018), Moreover, elevated RACK1 expression promotes the malignant progression of HCC (Duan et al. 2018).